相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts
Giuseppina Farina et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis
Minoru Hasegawa et al.
CLINICAL RHEUMATOLOGY (2011)
Endothelial Fli1 Deficiency Impairs Vascular Homeostasis A Role in Scleroderma Vasculopathy
Yoshihide Asano et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension
Revathi Rajkumar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Type I interferon system activation and association with disease manifestations in systemic sclerosis
Maija-Leena Eloranta et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
A Four-Gene Biomarker Predicts Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis
G. Farina et al.
ARTHRITIS AND RHEUMATISM (2010)
CXC Chemokine Ligand 4 (CXCL4) Is a Platelet-Derived Mediator of Experimental Liver Fibrosis
Mirko Moreno Zaldivar et al.
HEPATOLOGY (2010)
Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus
Timothy R. D. J. Radstake et al.
NATURE GENETICS (2010)
Polymorphisms in TBX21 and STAT4 Increase the Risk of Systemic Sclerosis Evidence of Possible Gene-Gene Interaction and Alterations in Th1/Th2 Cytokines
Pravitt Gourh et al.
ARTHRITIS AND RHEUMATISM (2009)
Association Between the IRF5 rs2004640 Functional Polymorphism and Systemic Sclerosis
P. Dieude et al.
ARTHRITIS AND RHEUMATISM (2009)
Innate immunity and inflammation in systemic sclerosis
Robert Lafyatis et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
The STAT4 gene influences the genetic predisposition to systemic sclerosis phenotype
B. Rueda et al.
HUMAN MOLECULAR GENETICS (2009)
The Metabolic Syndrome and Its Traits as Risk Factors for Subclinical Atherosclerosis
Suzanne Holewijn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression
Timothy R. D. J. Radstake et al.
PLOS ONE (2009)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
The innate immune system in SLE: type I interferons and dendritic cells
L. Roennblom et al.
LUPUS (2008)
The CXC-Chemokine CXCL4 Interacts with Integrins Implicated in Angiogenesis
Sallouha Aidoudi et al.
PLOS ONE (2008)
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis - a longitudinal study
A. Antonelli et al.
RHEUMATOLOGY (2008)
The immunobiology of systemic sclerosis
Y. Stephanie Gu et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients
T. C. T. M. van der Pouw Kraan et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome
JE Gottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH cytokine production
P Romagnani et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis
M Kodera et al.
ARTHRITIS AND RHEUMATISM (2005)
Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells
CY Liu et al.
JOURNAL OF IMMUNOLOGY (2005)
β thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis
O Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin
M Kubo et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)
A Scheja et al.
ARTHRITIS RESEARCH (2001)
分享论文
